WHO ICTRP trial
Open prospective randomized clinical trials of 5% ethanol-cisplatin in the…
ChiCTR-IPR-15006341 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-IPR-15006341 |
|---|---|
| Public title | Open prospective randomized clinical trials of 5% ethanol-cisplatin in the treatment of non-small cell lung cancer malignant pleural effusion |
| Scientific title | 5% ethanol-cisplatin in the treatment of non-small cell lung cancer malignant pleural effusion |
| Primary sponsor | Beijing Tsinghua Changgung Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | I (Phase I study) |
| Countries | China |
| Conditions | non-small cell lung cancer |
| Interventions | 1:Therapy with intravenous chemotherapy combined with pleural effusion drainage;2:Intravenous chemotherapy combined with CIS-Platinum intrapleural therapy;3:Intravenous chemotherapy combined with 5% ethanol and cisplatin injection therapy |
| Registration date | May 2, 2015 |
| Target size | 1:72;2:72;3:72 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: